Understanding Type 2 Inflammation

Video

In this video interview, Marc Serota, MD, discusses his research regarding type 2 inflammation, the future of treating it as 1 condition or 2, and why physicians should educate their patients about this type of inflammation.

Related Videos
Related Content

Analyzing the Safety of JAK Inhibitors in Atopic Dermatitis Treatment

September 26th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Navigating Topical Steroid Withdrawal and Extreme Adverse Reactions to Corticosteroids

September 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Dupilumab Steadily Reduces IgE Levels of Patients With Atopic Dermatitis

September 19th 2023

Roflumilast Cream Meets Primary Endpoint for Treatment of Atopic Dermatitis

September 19th 2023

Analyzing the Safety of JAK Inhibitors in Atopic Dermatitis Treatment

September 26th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Navigating Topical Steroid Withdrawal and Extreme Adverse Reactions to Corticosteroids

September 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Dupilumab Steadily Reduces IgE Levels of Patients With Atopic Dermatitis

September 19th 2023

Roflumilast Cream Meets Primary Endpoint for Treatment of Atopic Dermatitis

September 19th 2023

Analyzing the Safety of JAK Inhibitors in Atopic Dermatitis Treatment

September 26th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Navigating Topical Steroid Withdrawal and Extreme Adverse Reactions to Corticosteroids

September 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Dupilumab Steadily Reduces IgE Levels of Patients With Atopic Dermatitis

September 19th 2023

Roflumilast Cream Meets Primary Endpoint for Treatment of Atopic Dermatitis

September 19th 2023
© 2023 MJH Life Sciences

All rights reserved.